Tatsuro Jo

1.4k total citations
26 papers, 290 citations indexed

About

Tatsuro Jo is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Tatsuro Jo has authored 26 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Hematology and 7 papers in Genetics. Recurrent topics in Tatsuro Jo's work include T-cell and Retrovirus Studies (14 papers), Vector-Borne Animal Diseases (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Tatsuro Jo is often cited by papers focused on T-cell and Retrovirus Studies (14 papers), Vector-Borne Animal Diseases (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Tatsuro Jo collaborates with scholars based in Japan, United States and Russia. Tatsuro Jo's co-authors include Takashi Ishida, Kensei Tobinai, Yoshitaka Imaizumi, Yukiyoshi Moriuchi, Kunihiro Tsukasaki, Hiroshi Fujiwara, Naoya Taira, Kisato Nosaka, Shigeki Ito and Hitoshi Suzushima and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Tatsuro Jo

23 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuro Jo Japan 8 228 144 111 60 52 26 290
Toshimasa Kukita Japan 11 203 0.9× 110 0.8× 90 0.8× 24 0.4× 47 0.9× 29 335
S Tamori Japan 7 323 1.4× 159 1.1× 153 1.4× 40 0.7× 31 0.6× 13 372
Kentaro Yonekura Japan 12 265 1.2× 116 0.8× 87 0.8× 105 1.8× 57 1.1× 29 394
Ghada Kchour Lebanon 7 199 0.9× 129 0.9× 129 1.2× 19 0.3× 29 0.6× 9 306
H Nagoshi Japan 6 361 1.6× 258 1.8× 187 1.7× 72 1.2× 57 1.1× 12 422
Genji Takeuchi Japan 5 354 1.6× 118 0.8× 75 0.7× 140 2.3× 151 2.9× 7 444
K Uozumi Japan 5 394 1.7× 267 1.9× 217 2.0× 42 0.7× 131 2.5× 16 501
M Iwahashi Japan 9 233 1.0× 75 0.5× 89 0.8× 11 0.2× 42 0.8× 33 344
Hidehiro Itonaga Japan 11 158 0.7× 93 0.6× 70 0.6× 34 0.6× 38 0.7× 65 371
Hisashi Sohda Japan 10 413 1.8× 318 2.2× 267 2.4× 52 0.9× 55 1.1× 15 468

Countries citing papers authored by Tatsuro Jo

Since Specialization
Citations

This map shows the geographic impact of Tatsuro Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuro Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuro Jo more than expected).

Fields of papers citing papers by Tatsuro Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuro Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuro Jo. The network helps show where Tatsuro Jo may publish in the future.

Co-authorship network of co-authors of Tatsuro Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuro Jo. A scholar is included among the top collaborators of Tatsuro Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuro Jo. Tatsuro Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izutsu, Koji, Takayuki Ishikawa, Kazuyuki Shimada, et al.. (2025). Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL. International Journal of Hematology. 121(4). 483–493. 1 indexed citations
2.
Jo, Tatsuro, Takahiro Sakai, Ritsuko Kubota‐Koketsu, et al.. (2022). HTLV‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma. Cancer Medicine. 11(17). 3238–3250. 7 indexed citations
3.
Jo, Tatsuro, Ritsuko Kubota‐Koketsu, Takahiro Sakai, et al.. (2022). Live attenuated VZV vaccination induces antitumor immunity in ATLL patients. Cancer Immunology Immunotherapy. 72(4). 929–944. 4 indexed citations
4.
5.
6.
Jo, Tatsuro, Hiro-o Tominaga, Takahiro Sakai, et al.. (2020). Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma. Anticancer Research. 40(9). 5237–5243. 10 indexed citations
7.
8.
Jo, Tatsuro, Takahiro Sakai, Hiro-o Tominaga, et al.. (2020). Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin. Case Reports in Oncology. 13(3). 1402–1409. 2 indexed citations
9.
Izutsu, Koji, Yosuke Minami, Noriko Fukuhara, et al.. (2019). Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma. International Journal of Hematology. 111(3). 409–416. 5 indexed citations
10.
Jo, Tatsuro, Hiro-o Tominaga, Takahiro Sakai, et al.. (2019). Improved Overall Survival Among Newly Diagnosed Aggressive Adult T-Cell Leukemia/Lymphoma Patients Treated with Mogamulizumab Plus EPOCH Compared to Mogamulizumab Plus Vcap-AMP-Vecp. Blood. 134(Supplement_1). 4048–4048. 1 indexed citations
11.
12.
Ishida, Takashi, Atae Utsunomiya, Tatsuro Jo, et al.. (2017). Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies. Cancer Science. 108(10). 2022–2029. 52 indexed citations
13.
14.
Satoh, Shinya, Masatoshi Matsuo, Masako Iwanaga, et al.. (2017). Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki. British Journal of Haematology. 180(3). 381–390. 3 indexed citations
15.
Ishida, Takashi, Hiroshi Fujiwara, Kisato Nosaka, et al.. (2016). Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002. Journal of Clinical Oncology. 34(34). 4086–4093. 105 indexed citations
16.
Katsuya, Hiroo, Mototsugu Shimokawa, Kenji Ishitsuka, et al.. (2015). Prognostic index for chronic and smoldering types adult T-cell leukemia/lymphoma.. Journal of Clinical Oncology. 33(15_suppl). 8522–8522. 1 indexed citations
17.
18.
Kawano, Hiroaki, Tomayoshi Hayashi, Masamichi Eguchi, et al.. (2013). Cyclophosphamide-induced Cardiotoxicity with a Prolonged Clinical Course Diagnosed on an Endomyocardial Biopsy. Internal Medicine. 52(20). 2311–2315. 16 indexed citations
19.
Jo, Tatsuro, Takashi Ishida, Shigeki Takemoto, et al.. (2013). Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL).. Journal of Clinical Oncology. 31(15_suppl). 8506–8506. 12 indexed citations
20.
Jo, Tatsuro, et al.. (2012). Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine. Case Reports in Oncology. 5(2). 260–266. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimasa Kukita Breakdown of academic impact, for papers by S Tamori Breakdown of academic impact, for papers by Kentaro Yonekura Breakdown of academic impact, for papers by Ghada Kchour Breakdown of academic impact, for papers by H Nagoshi Breakdown of academic impact, for papers by Genji Takeuchi Breakdown of academic impact, for papers by K Uozumi Breakdown of academic impact, for papers by M Iwahashi Breakdown of academic impact, for papers by Hidehiro Itonaga Breakdown of academic impact, for papers by Hisashi Sohda
Rankless by CCL
2026